MiR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2

Biochemical and Biophysical Research Communications

Volumn 460, Issue 3, 2015, Pages 670-677

  Li, Xuesong ^a   Gong, Xuhai ^a   Chen, Jing ^b   Zhang, Jinghui ^c   Sun, Jiahang ^d   Guo, Mian ^d  

^a DAQING OILFIELD CO LTD   (China)

^b First Hospital of Daqing City   (China)

^c Department of Cardiology   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CDK; Cell cycle; Cyclin; Glioblastoma; miR 340

Indexed keywords

CDK6 PROTEIN, HUMAN; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 6; MICRORNA; MIRN340 MICRORNA, HUMAN; PRIMER DNA;

BRAIN TUMOR; CELL PROLIFERATION; GENETICS; GLIOBLASTOMA; HUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN D2; CYCLIN-DEPENDENT KINASE 6; DNA PRIMERS; GLIOBLASTOMA; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84937760476     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.088     Document Type: Article

References (30)

1. R.E. McLendon, and E.C. Halperin Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98 2003 1745 1748
2. H.W. Hwang, and J.T. Mendell MicroRNAs in cell proliferation, cell death, and tumorigenesis Br. J. Cancer 94 2006 776 780
3. E.V. Makeyev, and T. Maniatis Multilevel regulation of gene expression by microRNAs Science 319 2008 1789 1790
4. Z.S. Wu, Q. Wu, C.Q. Wang, X.N. Wang, J. Huang, J.J. Zhao, S.S. Mao, G.H. Zhang, X.C. Xu, and N. Zhang miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met Cancer 117 2011 2842 2852
5. S. Fernandez, M. Risolino, N. Mandia, F. Talotta, Y. Soini, M. Incoronato, G. Condorelli, S. Banfi, and P. Verde miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer Oncogene 2014 (Epub ahead of print)
6. Y. Sun, X. Zhao, Y. Zhou, and Y. Hu miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect Oncol. Rep. 28 2012 1346 1352
7. X. Zhou, M. Wei, and W. Wang MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 Biochem. Biophys. Res. Commun. 437 2013 653 658
8. H. Dong, L. Luo, S. Hong, H. Siu, Y. Xiao, L. Jin, R. Chen, and M. Xiong Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma BMC Syst. Biol. 4 2010 163
9. A. Gaur, D.A. Jewell, Y. Liang, D. Ridzon, J.H. Moore, C. Chen, V.R. Ambros, and M.A. Israel Characterization of microRNA expression levels and their biological correlates in human cancer cell lines Cancer Res. 67 2007 2456 2468
10. I. Lavon, D. Zrihan, A. Granit, O. Einstein, N. Fainstein, M.A. Cohen, M.A. Cohen, B. Zelikovitch, Y. Shoshan, S. Spektor, B.E. Reubinoff, Y. Felig, O. Gerlitz, T. Ben-Hur, Y. Smith, and T. Siegal Gliomas display a microRNA expression profile reminiscent of neural precursor cells Neuro Oncol. 12 2010 422 433
11. M. Malumbres, and M. Barbacid Cell cycle, CDKs and cancer: a changing paradigm Nat. Rev. Cancer 9 2009 153 166
12. J. Wang, Q. Wang, Y. Cui, Z.Y. Liu, W. Zhao, C.L. Wang, Y. Dong, L. Hou, G. Hu, C. Luo, J. Chen, and Y. Lu Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells J. Neurooncol 106 2012 473 484
13. P.Y. Lam, E. Di Tomaso, H.K. Ng, J.C. Pang, M.F. Roussel, and N.M. Hjelm Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme Br. J. Neurosurg. 14 2000 28 32
14. A.C. Bellail, J.J. Olson, and C. Hao SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression Nat. Commun. 5 2014 4234
15. L. Chen, K. Huang, L. Han, Z. Shi, K. Zhang, P. Pu, C. Jiang, and C. Kang beta-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma Int. J. Oncol. 39 2011 883 890
16. M. Karoui, C. Tresallet, C. Julie, U. Zimmermann, F. Staroz, A. Brams, C. Muti, C. Boulard, A.M. Robreau, H. Puy, R. Malafosse, C. Penna, F.R. Pruvot, J.P. Thiery, C. Boileau, P. Rougier, B. Nordlinger, F. Radvanyi, B. Franc, and H. Hofmann-Radvanyi Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases Br. J. Cancer 90 2004 1230 1234
17. S. Ely, M. Di Liberto, R. Niesvizky, L.B. Baughn, H.J. Cho, E.N. Hatada, D.M. Knowles, J. Lane, and S. Chen-Kiang Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma Cancer Res. 65 2005 11345 11353
18. R. Ueda, K. Ohkusu-Tsukada, N. Fusaki, A. Soeda, T. Kawase, Y. Kawakami, and M. Toda Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy Int. J. Cancer 126 2010 919 929
19. M.A. Dwyer, J.D. Joseph, H.E. Wade, M.L. Eaton, R.S. Kunder, D. Kazmin, C.Y. Chang, and D.P. McDonnell WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration Cancer Res. 70 2010 9298 9308
20. M. Carleton, M.A. Cleary, and P.S. Linsley MicroRNAs and cell cycle regulation Cell. Cycle 6 2007 2127 2132
21. F. Sun, H. Fu, Q. Liu, Y. Tie, J. Zhu, R. Xing, Z. Sun, and X. Zheng Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest FEBS Lett. 582 2008 1564 1568
22. R. Visone, L. Russo, P. Pallante, I. De Martino, A. Ferraro, V. Leone, E. Borbone, F. Petrocca, H. Alder, C.M. Croce, and A. Fusco MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle Endocr. Relat. Cancer 14 2007 791 798
23. E.A. Musgrove, C.E. Caldon, J. Barraclough, A. Stone, and R.L. Sutherland Cyclin D as a therapeutic target in cancer Nat. Rev. Cancer 11 2011 558 572
24. R. Koyama-Nasu, Y. Nasu-Nishimura, T. Todo, Y. Ino, N. Saito, H. Aburatani, K. Funato, K. Echizen, H. Sugano, R. Haruta, M. Matsui, R. Takahashi, E. Manabe, T. Oda, and T. Akiyama The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells Oncogene 32 2013 3840 3845
25. F. Iacopino, C. Angelucci, R. Piacentini, F. Biamonte, A. Mangiola, G. Maira, C. Grassi, and G. Sica Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones PLoS One 9 2014 e105166
26. X. Hong, K. Chedid, and S.N. Kalkanis Glioblastoma cell line-derived spheres in serumcontaining medium versus serum-free medium: a comparison of cancer stem cell properties Int. J. Oncol. 41 2012 1693 1700
27. H. Gal, G. Pandi, A.A. Kanner, Z. Ram, G. Lithwick-Yanai, N. Amariglio, G. Rechavi, and D. Givol MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells Biochem. Biophys. Res. Commun. 376 2008 86 90
28. R.M. Gangemi, F. Griffero, D. Marubbi, M. Perera, M.C. Capra, P. Malatesta, G.L. Ravetti, G.L. Zona, A. Daga, and G. Corte SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity Stem Cells 27 2009 40 48
29. J. Godlewski, M.O. Nowicki, A. Bronisz, S. Williams, A. Otsuki, G. Nuovo, A. Raychaudhury, H.B. Newton, E.A. Chiocca, and S. Lawler Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal Cancer Res. 68 2008 9125 9130
30. Z. Wang, Y. Li, D. Kong, A. Ahmad, S. Banerjee, and F.H. Sarkar Cross-talk between miRNA and notch signaling pathways in tumor development and progression Cancer Lett. 292 2010 141 148